36326 Federal Register / Vol. 87, No. 116 / Thursday, June 16, 2022 / Notices 

mature digital services; and providing 

the structure (including increasing 

transparency) and resources to ensure 

customer experience is a focal point for 

agency leadership. To support this, 

OMB Circular A–11 Section 280 

established government-wide standards 

for mature customer experience 

organizations in government and 

measurement. To enable Federal 

programs to deliver the experience 

taxpayers deserve, they must undertake 

three general categories of activities: 

conduct ongoing customer research, 

gather and share customer feedback, and 

test services and digital products. 

These data collection efforts may be 

either qualitative or quantitative in 

nature or may consist of mixed 

methods. Additionally, data may be 

collected via a variety of means, 

including but not limited to electronic 

or social media, direct or indirect 

observation (i.e., in person, video and 

audio collections), interviews, 

questionnaires, surveys, and focus 

groups. GSA will limit its inquiries to 

data collections that solicit strictly 

voluntary opinions or responses. 

The results of the data collected will 

be used to improve the delivery of 

Federal services and programs. It will 

include the creation of personas, 

customer journey maps, and reports and 

summaries of customer feedback data 

and user insights. It will also provide 

government-wide data on customer 

experience that can be displayed on 

performance.gov to help build 

transparency and accountability of 

Federal programs to the customers they 

serve. 

Method of Collection: 

GSA will collect this information by 

electronic means when possible, as well 

as by mail, fax, telephone, technical 

discussions, and in-person interviews. 

GSA may also utilize observational 

techniques to collect this information. 

Data: 

Form Number(s): None. 

Type of Review: New. 

B. Annual Reporting Burden 

Affected Public: Collections will be 

targeted to the solicitation of opinions 

from respondents who have experience 

with the program or may have 

experience with the program in the near 

future. For the purposes of this request, 

‘‘customers’’ are individuals, 

businesses, and organizations that 

interact with a Federal Government 

agency or program, either directly or via 

a Federal contractor. This could include 

individuals or households; businesses 

or other for-profit organizations; not-forprofit institutions; State, local or tribal 

governments; Federal government; and 

Universities. 

Estimated Number of Respondents: 

2,001,550. 

Estimated Time per Response: Varied, 

dependent upon the data collection 

method used. The possible response 

time to complete a questionnaire or 

survey may be 3 minutes or up to 2 

hours to participate in an interview. 

Estimated Total Annual Burden 

Hours: 101,125. 

Estimated Total Annual Cost to 

Public: $0. 

C. Public Comments 

GSA invites comments on: (a) 

Whether the proposed collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information will have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden (including hours and cost) 

of the proposed collection of 

information; (c) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Comments submitted in response to this 

notice will be summarized and/or 

included in the request for OMB 

approval of this information collection; 

they also will become a matter of public 

record. 

Beth Anne Killoran, 

Deputy Chief Information Officer. 

[FR Doc. 2022–12982 Filed 6–15–22; 8:45 am] 

BILLING CODE 6820–34–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; Study on 

the Conversion of Enrollment Slots 

From Head Start to Early Head Start 

(HS2EHS Study) (New Collection) 

AGENCY: Office of Planning, Research, 

and Evaluation, Administration for 

Children and Families, U.S. Department 

of Health and Human Services. 

ACTION: Request for public comment. 

SUMMARY: The Administration for 

Children and Families (ACF) at the U.S. 

Department of Health and Human 

Services (HHS) is proposing a new 

information collection, using qualitative 

case studies, to examine how and why 

Head Start grant recipients convert 

enrollment slots from Head Start to 

Early Head Start and the facilitators and 

barriers to the implementation of highquality Early Head Start services 

following conversion. This information 

collection aims to present an internally 

valid description of the experiences of 

up to six purposively selected cases, not 

to promote statistical generalization to 

different sites or service populations. 

DATES: Comments due within 30 days of 

publication. OMB must make a decision 

about the collection of information 

between 30 and 60 days after 

publication of this document in the 

Federal Register. Therefore, a comment 

is best assured of having its full effect 

if OMB receives it within 30 days of 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. You can also obtain 

copies of the proposed collection of 

information by emailing 

OPREinfocollection@acf.hhs.gov. All 

emailed requests should be identified by 

the title of the information collection. 

SUPPLEMENTARY INFORMATION:

Description: This primary data 

collection request for the Study on the 

Conversion of Enrollment Slots from 

Head Start to Early Head Start (HS2EHS 

Study) aims to gather qualitative data 

about the experiences of up to six grant 

recipients that have converted 

enrollment slots from Head Start to 

Early Head Start. The HS2EHS Study 

will collect information about (a) how 

and why each grant recipient converted 

enrollment slots from Head Start to 

Early Head Start; (b) strategic planning 

for and implementation of high-quality 

Early Head Start services following 

conversion; and (c) barriers and 

facilitators to the provision of highquality Early Head Start services that 

meet community needs. The HS2EHS 

team will also collect information about 

the state and local early care and 

education context and community need 

for Early Head Start services. 

Respondents: Head Start directors and 

staff, Head Start policy council 

members, Head Start Training and 

Technical Assistance staff, and state and 

local Early Care and Education leaders 

and community partners. 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 116 / Thursday, June 16, 2022 / Notices 36327 

ANNUAL BURDEN ESTIMATES

Instrument 

Number of 

respondents 

(total over 

request period) 

Number of 

responses per 

respondent 

(total over 

request period) 

Average 

burden per 

response 

(in hours) 

Total/annual 

burden 

(in hours) 

Coordination Activities (Coordinator) ....................................................... 6 1 3 18 

Prep Email Request (Director) ................................................................. 9 1 .5 5 

Preparatory Interview (Director, Onsite coordinator) ............................... 18 1 1 18 

Full Interview for Head Start Staff Protocol ............................................. 70 1 1.5 105 

Full Interview for Non-Head Start Staff Protocol ..................................... 12 1 1.5 18 

Estimated Total Annual Burden 

Hours: 164 hours. 

Authority: Head Start Act section 640 

[42 U.S.C. 9835]. 

Mary B. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2022–12967 Filed 6–15–22; 8:45 am] 

BILLING CODE 4184–22–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2022–D–0745] 

Voluntary Consensus Standards 

Recognition Program for Regenerative 

Medicine Therapies; Draft Guidance for 

Industry; Availability; Agency 

Information Collection Activities; 

Proposed Collection; Comment 

Request 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of availability. 

SUMMARY: The Food and Drug 

Administration (FDA or Agency) is 

announcing the availability of a draft 

document entitled ‘‘Voluntary 

Consensus Standards Recognition 

Program for Regenerative Medicine 

Therapies; Draft Guidance for Industry.’’ 

The draft guidance describes a 

standards recognition program for 

regenerative medicine therapies (SRP– 

RMT) at FDA’s Center for Biologics 

Evaluation and Research (CBER) 

designed to identify Voluntary 

Consensus Standards (VCS) to facilitate 

the development and assessment of 

regenerative medicine therapy (RMT) 

products regulated by CBER when such 

standards are appropriate. The 

voluntary use of recognized VCS can 

assist stakeholders in more efficiently 

meeting regulatory requirements and 

increasing regulatory predictability for 

RMT products. The program is modeled 

after the formal standards and 

conformity assessment program (S– 

CAP) for medical devices. 

DATES: Submit either electronic or 

written comments on the draft guidance 

by September 14, 2022 to ensure that 

the Agency considers your comment on 

this draft guidance before it begins work 

on the final version of the guidance. 

Submit either electronic or written 

comments on the collection of 

information by August 15, 2022. 

ADDRESSES: You may submit comments 

on any guidance at any time as follows: 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to https://

www.regulations.gov will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be 

posted on https://www.regulations.gov. 

• If you want to submit a comment 

with confidential information that you 

do not wish to be made available to the 

public, submit the comment as a 

written/paper submission and in the 

manner detailed (see ‘‘Written/Paper 

Submissions’’ and ‘‘Instructions’’). 

Written/Paper Submissions 

Submit written/paper submissions as 

follows: 

• Mail/Hand Delivery/Courier (for 

written/paper submissions): Dockets 

Management Staff (HFA–305), Food and 

Drug Administration, 5630 Fishers 

Lane, Rm. 1061, Rockville, MD 20852. 

• For written/paper comments 

submitted to the Dockets Management 

Staff, FDA will post your comment, as 

well as any attachments, except for 

information submitted, marked and 

identified, as confidential, if submitted 

as detailed in ‘‘Instructions.’’ 

Instructions: All submissions received 

must include the Docket No. FDA– 

2022–D–0745 for ‘‘Voluntary Consensus 

Standards Recognition Program for 

Regenerative Medicine Therapies; Draft 

Guidance for Industry.’’ Received 

comments will be placed in the docket 

and, except for those submitted as 

‘‘Confidential Submissions,’’ publicly 

viewable at https://www.regulations.gov 

or at the Dockets Management Staff 

between 9 a.m. and 4 p.m., Monday 

through Friday, 240–402–7500. 

• Confidential Submissions—To 

submit a comment with confidential 

information that you do not wish to be 

made publicly available, submit your 

comments only as a written/paper 

submission. You should submit two 

copies total. One copy will include the 

information you claim to be confidential 

with a heading or cover note that states 

‘‘THIS DOCUMENT CONTAINS 

CONFIDENTIAL INFORMATION.’’ The 

Agency will review this copy, including 

the claimed confidential information, in 

its consideration of comments. The 

second copy, which will have the 

claimed confidential information 

redacted/blacked out, will be available 

for public viewing and posted on 

https://www.regulations.gov. Submit 

both copies to the Dockets Management 

Staff. If you do not wish your name and 

contact information to be made publicly 

available, you can provide this 

information on the cover sheet and not 

in the body of your comments and you 

must identify this information as 

‘‘confidential.’’ Any information marked 

as ‘‘confidential’’ will not be disclosed 

except in accordance with 21 CFR 10.20 

and other applicable disclosure law. For 

more information about FDA’s posting 

of comments to public dockets, see 80 

FR 56469, September 18, 2015, or access 

the information at: https://

www.govinfo.gov/content/pkg/FR-2015- 

09-18/pdf/2015-23389.pdf. 

Docket: For access to the docket to 

read background documents or the 


khammond on DSKJM1Z7X2PROD with NOTICES